Clinical Value of Prostacyclin and its Analogs in the Management of Pulmonary Arterial Hypertension

E-ISSN： 1875-6212|1|2|171-181

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.1, Iss.2, 2003-06, pp. : 171-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulmonary Arterial Hypertension in Systemic Sclerosis: Clinical Manifestations, Pathophysiology, Evaluation, and Management

By Ramirez Allan

Treatments in Respiratory Medicine, Vol. 3, Iss. 6, 2004-01 ,pp. : 339-352

Adis International

Access to resources Recommend Favorite

Clinical Pharmacotherapy and Drug Development for Pulmonary Arterial Hypertension

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 180-188

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Management of Pulmonary Arterial Hypertension

Current Respiratory Medicine Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 41-48

Bentham Science Publishers

Access to resources Recommend Favorite

Prostanoids for Pulmonary Arterial Hypertension

By Galiè N. Manes A. Branzi A.

American Journal of Respiratory Medicine, Vol. 2, Iss. 2, 2003-01 ,pp. : 123-137

Adis International

Access to resources Recommend Favorite

Ambrisentan for pulmonary arterial hypertension

By Rubin Lewis J Dufton Christopher Gerber Michael J

Future Cardiology, Vol. 1, Iss. 4, 2005-07 ,pp. : 425-432

Future Medicine

Access to resources Recommend Favorite